comparemela.com

Latest Breaking News On - Inhibitors summit - Page 1 : comparemela.com

Rakovina Therapeutics Inc Announces Q1 2023 Financial Results and Provides Corporate Update

VANCOUVER, British Columbia, May 31, 2023 Rakovina Therapeutics Inc. , a biopharmaceutical company dedicated to improving the lives of cancer patients through development of novel DNA-damage. | May 31, 2023

United statesUnited kingdomBritish columbiaJeffrey bachaSummaryfinancial resultsforthequarterendedmarchDrug administrationAmerican association of cancer researchRakovina therapeutics incHealth canadaAmerican associationCancer researchNational research councilCanada industrial research assistance programRakovina therapeuticsInhibitors summitFinancial resultsforthequarterendedmarch

Rakovina Therapeutics Inc Announces 2022 Financial Results

VANCOUVER, British Columbia, May 01, 2023 (GLOBE NEWSWIRE) Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company”) a biopharmaceutical company.

Comunidad autonoma de catalunaUnited kingdomBritish columbiaUnited statesDavid hymanJeffrey bachaDrug administrationHealth canadaProactive investors nort america incRegulation services providerNational brain tumor societyAmerican association of cancer researchResearch developmentNational research council of canadaVenture exchangeRakovina therapeutics inc

vimarsana © 2020. All Rights Reserved.